CYTOMX THERAPEUTICS INC (CTMX) Stock Analyst Earnings Estimates
NASDAQ:CTMX - Nasdaq - US23284F1057 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 37.3M -62.85% | 53.2M 42.63% | 101.214M 90.25% | 124.04M 22.55% | 77.796M -37.28% | 34.349M -55.85% | 44.268M 28.88% | 71.89M 62.40% | 200.27M 178.58% | 314.58M 57.08% | 415.16M 31.97% | 513.81M 23.76% | |
| EBITDA YoY % growth | -113.3M -145.77% | -91.2M 19.51% | -4.309M 95.28% | -6.12M -42.03% | -48.96M -700.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -116M -138.68% | -93.6M 19.31% | -6.484M 93.07% | -10.7M -65.02% | -51.645M -382.67% | -86.4M -67.30% | -89.822M -3.96% | -60.01M 33.19% | 50.31M 183.84% | 144.82M 187.86% | 217.37M 50.10% | 289.73M 33.29% | |
| Operating Margin | -310.99% | -175.94% | -6.41% | -8.63% | -66.38% | -251.53% | -202.90% | -83.48% | 25.12% | 46.04% | 52.36% | 56.39% | |
| EPS YoY % growth | -1.31 -81.94% | -1.52 -16.03% | -0.02 98.68% | -0.04 -118.59% | -0.47 -972.26% | -0.75 -58.95% | -0.94 -25.94% | -0.47 50.00% | 0.70 250.00% | 1.70 142.03% | 2.64 55.09% | 2.81 6.18% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 -2,096.24% | -0.09 -151.45% | -0.10 -23.25% | -0.11 -250.57% | -0.16 22.33% | -0.24 -171.72% | -0.24 -138.96% | -0.24 -128.39% | -0.25 -59.21% |
| Revenue Q2Q % growth | 19.805M -25.56% | 17.34M -58.18% | 16.83M -32.99% | 17.085M -48.90% | 15.81M -20.17% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -14.28M -1,010.13% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.203M -2,903.84% | -11.118M -195.38% | -9.333M -10.42% | -9.894M -340.67% | -11.39M 37.43% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.07 75.00% | -0.18 | 0.25 | 139.87% |
| Q2 2024 Q2Q % growth | -0.08 -300.00% | -0.15 | 0.07 | 45.28% |
| Q1 2024 Q2Q % growth | 0.17 440.00% | -0.08 | 0.25 | 301.22% |
| Q4 2023 Q2Q % growth | 0.01 102.33% | -0.03 | 0.04 | 134.32% |
| Q3 2023 Q2Q % growth | 0.04 111.43% | -0.19 | 0.23 | 120.76% |
| Q2 2023 Q2Q % growth | -0.02 94.59% | -0.21 | 0.19 | 90.44% |
| Q1 2023 Q2Q % growth | -0.05 86.49% | -0.11 | 0.06 | 53.65% |
| Q4 2022 Q2Q % growth | -0.43 -7.50% | -0.24 | -0.19 | -78.96% |
| Q3 2022 Q2Q % growth | -0.35 | -0.31 | -0.04 | -12.30% |
| Q2 2022 Q2Q % growth | -0.37 -23.33% | -0.37 | 0.00 | -0.76% |
| Q1 2022 Q2Q % growth | -0.37 -42.31% | -0.37 | 0.00 | 0.16% |
| Q4 2021 Q2Q % growth | -0.40 -25.00% | -0.29 | -0.11 | -38.95% |
| Q3 2021 Q2Q % growth | -0.35 -9.37% | -0.32 | -0.03 | -9.80% |
| Q2 2021 Q2Q % growth | -0.30 11.76% | -0.33 | 0.03 | 7.88% |
| Q1 2021 Q2Q % growth | -0.26 -200.00% | -0.35 | 0.09 | 26.29% |
| Q4 2020 Q2Q % growth | -0.32 58.97% | -0.51 | 0.19 | 37.70% |
| Q3 2020 Q2Q % growth | -0.32 38.46% | -0.49 | 0.17 | 34.13% |
| Q2 2020 Q2Q % growth | -0.34 46.88% | 0.16 | -0.50 | -313.13% |
| Q1 2020 Q2Q % growth | 0.26 183.87% | -0.47 | 0.73 | 155.29% |
| Q4 2019 Q2Q % growth | -0.78 | -0.48 | -0.30 | -62.77% |
| Q3 2019 Q2Q % growth | -0.52 | -0.52 | 0.00 | 0.95% |
| Q2 2019 Q2Q % growth | -0.64 | -0.58 | -0.06 | -10.45% |
| Q1 2019 Q2Q % growth | -0.31 | -0.54 | 0.23 | 43.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 33.432M 26.71% | 17.865M | 15.567M | 87.14% |
| Q2 2024 Q2Q % growth | 25.115M 1.58% | 20.395M | 4.72M | 23.14% |
| Q1 2024 Q2Q % growth | 41.463M 76.45% | 21.863M | 19.6M | 89.65% |
| Q4 2023 Q2Q % growth | 26.607M 2,700.74% | 21.464M | 5.143M | 23.96% |
| Q3 2023 Q2Q % growth | 26.384M 136.63% | 14.424M | 11.96M | 82.92% |
| Q2 2023 Q2Q % growth | 24.724M 92.40% | 14.159M | 10.565M | 74.62% |
| Q1 2023 Q2Q % growth | 23.499M 159.94% | 19.98M | 3.519M | 17.61% |
| Q4 2022 Q2Q % growth | 950K 107.58% | 18.204M | -17.254M | -94.78% |
| Q3 2022 Q2Q % growth | 11.15M -36.61% | 18.516M | -7.366M | -39.78% |
| Q2 2022 Q2Q % growth | 12.85M -21.12% | 18.259M | -5.409M | -29.62% |
| Q1 2022 Q2Q % growth | 9.04M -43.39% | 21.077M | -12.037M | -57.11% |
| Q4 2021 Q2Q % growth | -12.53M -176.54% | 25.003M | -37.533M | -150.11% |
| Q3 2021 Q2Q % growth | 17.59M -1.12% | 18.446M | -856K | -4.64% |
| Q2 2021 Q2Q % growth | 16.29M -1.93% | 17.202M | -912K | -5.30% |
| Q1 2021 Q2Q % growth | 15.97M -67.80% | 15.735M | 235K | 1.49% |
| Q4 2020 Q2Q % growth | 16.37M 97.71% | 15.718M | 652K | 4.15% |
| Q3 2020 Q2Q % growth | 17.79M 66.11% | 16.67M | 1.12M | 6.72% |
| Q2 2020 Q2Q % growth | 16.61M 84.35% | 49.174M | -32.564M | -66.22% |
| Q1 2020 Q2Q % growth | 49.59M 68.16% | 20.276M | 29.314M | 144.57% |
| Q4 2019 Q2Q % growth | 8.28M | 17.719M | -9.439M | -53.27% |
| Q3 2019 Q2Q % growth | 10.71M | 18.424M | -7.714M | -41.87% |
| Q2 2019 Q2Q % growth | 9.01M | 16.913M | -7.903M | -46.73% |
| Q1 2019 Q2Q % growth | 29.49M | 13.126M | 16.364M | 124.67% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.53% | 16.72% | 0% | 83.93% |
| Revenue | 0.6% | 18.6% | 0% | 9.62% |